After being fired, I became the light of medicine

Chapter 111 Lin George, who loves to speak English! (Additional chapter for the Annual Ring Empire!)

Wang Guilan, 58 years old, is from Shanghai.

Four years ago, her husband was sent to the hospital because of bloody stools. After the examination, the results made her feel like the sky was falling.

Cirrhosis, decompensated stage.

At first she wasn't quite sure what the decompensation stage was, but she understood after the doctor changed the term.

Late stage of liver cirrhosis.

Fortunately, her family is well-off, she is a native of Shanghai, and her children are also financially well off. After careful treatment, she has finally been able to get through the past two years in peace.

but,

She has always been very worried. After several years of care, she has deeply understood that the mortality rate of late-stage liver cirrhosis is extremely high. If you are not careful, you may die from internal bleeding any day.

It was not until more than half a year ago that Tsingshan Pharmaceutical suddenly announced a piece of news to the public, announcing that it had discovered a drug that can promote liver cell regeneration and reverse cirrhosis!

This made her and her husband very excited. After thinking about it, they decided to move their family to Chengdu to receive treatment with Qingshan Pharmaceutical's new drug as soon as possible.

But her husband didn't catch up with the first phase of clinical trials, and the key point is -

The 20 patients with cirrhosis who participated in the clinical trial gave a low evaluation of the effectiveness of Qingshan Pharmaceutical's "hepatocyte activator".

Perhaps it was because the medication time was too short, or perhaps Qingshan Pharmaceutical had not yet found a more suitable drug ingredient. In short, Wang Guilan was a little disappointed.

This made her hesitate and she missed the opportunity for the Phase II clinical trial.

Now, looking at the latest liver drug research and development results of Novartis, a well-known international pharmaceutical company, especially the sentence "Long-term use of this drug can also prevent the further development of liver cirrhosis."

She was moved.

Novartis, she knows about it!
The leukemia drug Gleevec sold in the movie “Dying to Survive” is produced by this company!
“I must find a way to get a few bottles from America!”

For other people, it is difficult to go to the United States to buy imported medicines, but for her... it is not completely impossible.

She thought of her nephew.

Her nephew works at the HSBC headquarters in Shanghai. He is a middle-level manager and often travels to the UK and the US on business trips.

"Tell him about this first, and then help buy some for him when he's on a business trip. I'm sure Guofu will help with this matter."

Thinking of this, Wang Guilan no longer hesitated, picked up the phone and started looking through her nephew's address book.

"Lin Guofu..."

"This is it."

Beep...beep...beep.

The call is connected.

"Guofu, I'm Wang Guilan, your aunt."

There was silence on the other end of the phone for several seconds.

"Aunt, I've told you so many times, don't call me Guo Fu, my name is Lin George, you can call me George!"

"Okay, okay, George Lin."

Wang Guilan was speechless. Perhaps her nephew had worked at HSBC for too long that he no longer wanted his own name and instead chose an English name.

Moreover, the mixture of Chinese and English made it difficult for her to understand.

"George, I'm sorry, Auntie doesn't understand English. Can you speak Chinese?"

The phone was silent for a few seconds again, and then Lin George's voice was heard.

"Okay, Auntie."

"Hey, good boy!"

After a simple opening remark, Wang Guilan did not go straight to the point. She was used to chatting about family matters first.

"George, last year I heard that you had 'plastic anemia'. Your uncle was in the hospital at that time, so I didn't have time to call you.

I saw on the news that this disease can be cured. Have you tried it?"

"It is said that this drug was developed by Qingshan Pharmaceutical, right?"

When he heard about Qingshan Pharmaceutical, Lin George's face darkened. He would never forget that he had flown to the best Royal London Hospital in the UK to receive treatment.

The world-famous Dr. Richard told himself: Go back, we can’t cure you…

"Guofu, oh, George, are you listening? Hello?"

"heard it."

Lin George couldn't help but take a deep breath:

"Aunt, I'm cured."

"Oh, it's just as I thought. It's targeting the thing developed by Qingshan Pharmaceutical, right?"

"um, yes."

When Lin George heard the name of Qingshan Pharmaceutical again, his teeth were about to break.

However, the aunt did not seem to notice at all, and continued:

"Which hospital did you go to for treatment?"

Hearing this, Lin George felt like he was going crazy.

He has always looked down on the domestic medical system, otherwise he would not have traveled all the way to the UK for medical treatment.

He originally planned to go to Hong Kong for an injection, but Queen Mary Hospital did not have "ITG human ovarian hormone". In desperation, between illness and prejudice, he chose to live and received "ITG human ovarian hormone" treatment in a tertiary hospital in Shanghai.

This is also a lifelong shame for him.

Thinking of this, he finally couldn't help but say:
"Aunt, please get down to business. What's the matter with you calling today?" Aunt also came back to her senses and her tone suddenly became anxious.

"Guofu, you know that your uncle was diagnosed with advanced liver cirrhosis four years ago."

"Recently I saw a piece of news saying that Novartis in the United States has developed a new drug that can prevent the progression of liver cirrhosis, so..."

"Auntie thought that you often go to the United States on business trips, so if it's convenient, please help me and your uncle bring back a few boxes of medicine.

Also, I only saw the relevant information online, and I don’t know the specific situation or when it will be launched. Since you are good at English, can you help us learn more about it? "

Novartis?

Lin George's eyes lit up. He had a good impression of Novartis, which was a top pharmaceutical company that developed the miracle drug Gleevec and benefited countless blood disease patients!

This favor must be done!

"Aunt, there's no problem with this matter. Leave it to me."

"Send me the name of the drug later, and I'll check it for you on the Internet."

"Okay, okay, thank you, George."

Lin George hung up the phone, and after receiving the name of Novartis' new drug LivClearX, he quickly began to search for related information on the Internet.

It doesn’t matter if you don’t look at it, but once you do, you will be surprised!

This medicine can not only slow down the progression of cirrhosis as my aunt said, but it can also treat fatty liver, protect the liver, and prevent liver cancer and cirrhosis.

"Hiss, Novartis was able to develop this kind of drug. It really deserves to be the light of medicine in the world!"

The only downside is that the Phase II clinical trial has just ended, so it will take some time before the product can be put on the market.

However, good medicine is worth the wait!

While George Lin was discussing the details of the new drug "LivClearX" with his aunt, the Phase II clinical trial of Tsingshan Pharmaceutical's "Hepatocyte Regeneration Activator" was also progressing in an orderly manner.

Because cirrhosis is a complicated disease, Zhang Yang gradually discovered that even after adjusting the drug's activating component to 70%, the "hepatocyte activator" did not reverse as quickly as imagined.

After discussing with Wei Tian and others, everyone agreed that long-term medication would be needed for at least three months before obvious effects could be seen.

Zhang Yang simply stopped being anxious and began to arrange all his previous ideas and work.

The first is the project development of the second-generation "Qingshan Avaqubopa Tablets".

Zhang Yang asked the drug research and development center to set up a "Qingshan Afa" project team, not to develop the next generation of drugs within one or two years,
It just expressed the hope that the next generation of "Qingshan Afa" can improve the platelet treatment effect by at least 10% on the current basis, while minimizing side effects.

The same is true for "ITG eotopic hormone". A special research and development team has been established based on "ITG human eotopic hormone", hoping to gain some inspiration for the cure of leukemia through "ITG".

Simultaneously,

Zhang Yang also set up a "fatty liver" drug research and development team.

He is not satisfied with the therapeutic effect of "hepatocyte regeneration activator". He hopes to develop a drug ingredient that can effectively decompose liver fat based on "hepatocyte promotion" and completely solve the problem of fatty liver.

These projects can be regarded as the first batch of R&D projects of Qingshan Pharmaceutical's Drug R&D Center in the true sense, and they also pose a considerable challenge to the center.

Fortunately, after two years of development, the Drug Research Center already has more than 80 drug researchers and four project teams.

The team assigned to the task began to apply for R&D funds and to sort out R&D nodes. Zhang Yang was naturally not stingy with the scientific research expenses. There were 122.5 billion in the account, and it was still making continuous profits.

Each project has been allocated 100 million yuan, and once a project makes real progress, more scientific research funds will be invested in the future.

Finally, Zhang Yang handed over the initial information of the newly obtained "Kidney Toxin Clearing Dialysis Replacement Needle" to Wei Tian, ​​and Wei Tian led the rest of the research and development team to start the project research and development.

After arranging all the R&D matters, the entire drug R&D center of Qingshan Pharmaceutical was finally fully put on track.

Currently, each project team has 21 people, led by two doctoral supervisors, and the rest are drug researchers, statisticians, and laboratory technicians;

At the same time, with the progress of the project and the development of Tsingshan Pharmaceutical, each project team can expand more researchers in the future.

At this point, Tsingshan Pharmaceutical’s own R&D team was finally established.

After finishing these things, a month passed in a flash.

Before Zhang Yang could turn his attention back to the "hepatocyte activator", Lucas from GlaxoSmithKline in the UK was the first to bring good news.

The "ITG Human Myelopoietin" that was previously undergoing clinical development in the UK has finally passed the Phase III clinical trial and will now be officially approved for sale.

Zhang Yang certainly doesn’t expect the drug to sell well in the UK, after all, there are only 40 patients with aplastic anemia in the British Isles…

However, the price of one tube sold to GlaxoSmithKline was US$4500!

It feels great to earn US dollars.

Just when Zhang Yang was hesitating whether to let GlaxoSmithKline conduct clinical trials of the "hepatocyte activator" in the UK,

Lucas, who was shocked by Zhang Yang's GDP theory, politely declined.

He still hopes to wait for the results of Qingshan Pharmaceutical's Phase III clinical trial, or even wait until it goes on the market before deciding whether to introduce it.

Zhang Yang couldn't help but sigh that Friedman, a Jew, was indeed a ruthless capitalist.

But his vision and courage are indeed far beyond many people.

Speak of the devil and he will appear. Just when Zhang Yang was thinking of Friedman, the Jew, Friedman informed him of the latest developments of the new drug "LivClearX".

"Zhang, our 'LivClearX' has now officially started Phase III clinical trials!"

"My God, you have no idea how popular the test center was the day we started recruiting!"

"Everyone is paying attention to our drug now, Zhang, we are going to get rich."

……

PS: I'm adding the first chapter for Nian Lun! There are 3 more chapters left for rewards.

(End of this chapter)